OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action
Stacy G. Wendell, Hao Fan, Cheng Zhang
Pharmacological Reviews (2019) Vol. 72, Iss. 1, pp. 1-49
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104

Leukotriene receptors as potential therapeutic targets
Takehiko Yokomizo, Motonao Nakamura, Takao Shimizu
Journal of Clinical Investigation (2018) Vol. 128, Iss. 7, pp. 2691-2701
Open Access | Times Cited: 153

Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development
Jennifer Kricker, Clive P. Page, Fridrik Runar Gardarsson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1404-1433
Open Access | Times Cited: 58

A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention
Indiwari Gopallawa, Ruchika Dehinwal, Vaibhav Bhatia, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36

GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1

Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
H Liu, Josefa Hofmann, I. Fish, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 47, pp. 12046-12050
Open Access | Times Cited: 79

Structures of the Human PGD2 Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition
Lei Wang, Dandan Yao, R. N. V. Krishna Deepak, et al.
Molecular Cell (2018) Vol. 72, Iss. 1, pp. 48-59.e4
Open Access | Times Cited: 69

GPCR mediated control of calcium dynamics: A systems perspective
Vaibhav Dhyani, Suman Gare, Rishikesh Kumar Gupta, et al.
Cellular Signalling (2020) Vol. 74, pp. 109717-109717
Open Access | Times Cited: 56

Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies
Andrew J. Haak, Merrick T. Ducharme, Ana M. Diaz Espinosa, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 3, pp. 172-182
Open Access | Times Cited: 55

Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling
Dana J. Ramms, Francesco Raimondi, Nadia Arang, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1326-1368
Open Access | Times Cited: 52

The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy
Kijeong Lee, Sang Hag Lee, Tae Hoon Kim
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1851-1851
Open Access | Times Cited: 51

Pharmacology of Adenosine Receptors: Recent Advancements
Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1387-1387
Open Access | Times Cited: 16

In silico off-target profiling for enhanced drug safety assessment
Jin Liu, Yike Gui, Jingxin Rao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2927-2941
Open Access | Times Cited: 6

On some neighbourhood degree-based topological indices with QSPR analysis of asthma drugs
Deepa Balasubramaniyan, C. Natarajan
The European Physical Journal Plus (2023) Vol. 138, Iss. 9
Closed Access | Times Cited: 14

Implication of Central β2 Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease
A. Wang, Marc Since, Patrick Dallemagne, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 4
Open Access

A2B adenosine receptor signaling and regulation
Zhan-Guo Gao, Mansour Haddad, Kenneth A. Jacobson
Purinergic Signalling (2024)
Closed Access | Times Cited: 4

Comprehensive sequencing of the lung neuroimmune landscape in response to asthmatic induction
Hayden McSwiggin, Rui Wang, Rubens Daniel Miserani Magalhães, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Recent Advances in Nanomaterials for Asthma Treatment
Xu Zuo, Xiaoping Guo, Yinuo Gu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14427-14427
Open Access | Times Cited: 16

HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation
Zhishuo Wang, Chenghua Yan, Qizhen Du, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 404-418
Closed Access | Times Cited: 10

QSPR analysis of anti‐asthmatic drugs using some new distance‐based topological indices: A comparative study
Deepa Balasubramaniyan, C. Natarajan, Vignesh Ravi, et al.
International Journal of Quantum Chemistry (2024) Vol. 124, Iss. 9
Closed Access | Times Cited: 3

Purinergic Receptors in the Airways: Potential Therapeutic Targets for Asthma?
Rebecca Thompson, Ian Sayers, Katja Kuokkanen, et al.
Frontiers in Allergy (2021) Vol. 2
Open Access | Times Cited: 23

Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System
Elisabetta Coppi, Federica Cherchi, Martina Venturini, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1890-1890
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top